SAFETY, EFFICACY, AND EFFECTIVENESS OF BRENTUXIMAB VEDOTIN IN THE TREATMENT OF RELAPSED OR REFRACTORY CD30+ HODGKIN LYMPHOMA AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION: A SYSTEMATIC REVIEW. REMUNOM, [S. l.], v. 2, n. 02, p. 1–23, 2026. DOI: 10.66104/hkgjcw62. Disponível em: https://remunom.ojsbr.com/multidisciplinar/article/view/5503. Acesso em: 25 feb. 2026.